Owl Creek Asset Management’s TriSalus Life Sciences Warrant TLSIW Stock Holding History

Owl Creek Asset Management’s Portfolio TLSIW Stock Details TLSIW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-13,333	Closed	-$1K	–	255
2022 Q3	$1K	Hold	13,333	–	–	﹤0.01%	341
2022 Q2	$1K	Hold	13,333	–	–	﹤0.01%	393
2022 Q1	$3K	Hold	13,333	–	–	﹤0.01%	414
2021 Q4	$7K	Hold	13,333	–	–	﹤0.01%	435
2021 Q3	$11K	Hold	13,333	–	–	﹤0.01%	413
2021 Q2	$14K	Hold	13,333	–	–	﹤0.01%	378
2021 Q1	$15K	Buy	+13,333	New	+$24.1K	﹤0.01%	309

Other funds holding TLSIW

RCM

Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return

AGC

Angelo Gordon & Co New York $1.06B AUM 47.95% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return

Vestcor Inc Fredericton, New Brunswick, Canada $3.63B AUM 21.49% 1-Year Est. Return

MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Owl Creek Asset Management's TLSIW Position: Q4 2022 in Review

Owl Creek Asset Management sold out of TriSalus Life Sciences Warrant (TLSIW) in Q4 2022, closing a stake of 13,333 shares — an estimated $1K sold.

Owl Creek Asset Management first reported a position in TLSIW in Q1 2021 and held it in 7 quarters. The position peaked at $15K in Q1 2021. 29 funds tracked by Wall St. Rank hold TLSIW as of Q4 2022.

Owl Creek Asset Management reported no remaining TriSalus Life Sciences Warrant position as of Q4 2022 after selling out during the quarter.
Owl Creek Asset Management sold 13,333 TriSalus Life Sciences Warrant shares in Q4 2022, an estimated $1K.
Owl Creek Asset Management first reported a position in TriSalus Life Sciences Warrant in Q1 2021 and held it in 7 quarters.
Owl Creek Asset Management's TriSalus Life Sciences Warrant position peaked at $15K in Q1 2021.
29 funds tracked by Wall St. Rank held TriSalus Life Sciences Warrant as of Q4 2022.

Based on Owl Creek Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.